Day: August 14, 2023

Getty Images Reports Preliminary Second Quarter 2023 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. “Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported preliminary financial results for the second quarter ended June 30, 2023. “The second quarter was a more challenging environment; however, we continue to see increased customer commitment and content utilization, notably through growth in subscriptions, new customers and in our Corporate sector,” said Craig Peters, Chief Executive Officer for Getty Images. “The second quarter also saw us launch major search improvements through Natural Language search, providing significantly improved returns against any customer query. We also continue to make progress in developing a truly differentiated generative AI service that addresses customers’ commercial...

Continue reading

ADDvantage Technologies Reports Financial Results for the Quarter Ended June 30, 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

CARROLLTON, Texas, Aug. 14, 2023 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today reported financial results for the three and six months ended June 30, 2023, the second quarter of 2023. Effective September 2022, the Company has changed its fiscal year end from September 30 to December 31, and this report reflects that adjustment. “Both segments of our business were impacted by macro-headwinds during the quarter,” commented Joe Hart, Chief Executive Officer. “Orders for used and refurbished equipment in our Telco segment have been drastically reduced due to the overstocking done in 2022 by our customers and we have been forced to wait for the burn off of that excess inventory by the optical network providers sometime later this year. Our Wireless...

Continue reading

Definitive Healthcare acquires Populi

Written by Customer Service on . Posted in Mergers And Acquisitions.

Acquisition broadens Definitive Healthcare’s suite of healthcare commercial intelligence solutions with new data, analytics, and visualization tools tailor-built for the provider market FRAMINGHAM, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced its acquisition of Populi, a provider-focused data and analytics company that works with healthcare organizations to optimize physician relationships, reduce network leakage, and expand market share. This acquisition furthers Definitive Healthcare’s commitment to leadership in the healthcare commercial intelligence market across the entire healthcare ecosystem, including life sciences, providers, and diversified industries. “Populi provides the dynamic, highly visual commercial intelligence...

Continue reading

Societal CDMO Reports Second Quarter 2023 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Recorded Q2 Revenue of $21.8 Million Signed Multiple New Business Agreements with New and Existing Customers Secured Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency; Allows Expansion into Manufacture of Psychedelic Drug Products Company to Host Webcast Today at 4:30 p.m. ET SAN DIEGO and GAINESVILLE, Ga., Aug. 14, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today reported financial results for the second quarter and six months ended June 30, 2023. “The second quarter was a highly productive period.  During the quarter, we continued to aggressively pursue and win new business, as well as...

Continue reading

Mustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

WORCESTER, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2023. Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “In the second quarter of 2023, Mustang continued to advance the development of our lead clinical candidate MB-106, a CD20-targeted, autologous CAR T cell therapy to treat relapsed or refractory B-cell non-Hodgkin lymphomas (“B-NHL”) and chronic lymphocytic leukemia (“CLL”). Data from the ongoing Phase 1/2 single-institution clinical trial at Fred Hutchinson...

Continue reading

Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

OLPRUVA™ (sodium phenylbutyrate) kits now available in all dosage strengths and ready to ship to patients NEWTON, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update. “The second quarter of 2023 marked continued progress for Acer as we execute on our OLPRUVA™ launch strategy,” said Chris Schelling, CEO and Founder of Acer. “We are pleased to offer OLPRUVA™ in the U.S. to certain UCD patients as a novel alternative option to current treatments that was specifically designed for palatability and...

Continue reading

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

TCR-T Library Phase 1/2 trial achieved an 83% disease control rate of six evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all evaluable patients Company to wind down TCR-T Library Phase 1/2 trial and concurrently explore potential partnering opportunities for the hunTR® platform as well as broad strategic alternatives Reducing headcount by approximately 60% while retaining key hunTR® R&D capabilities HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced financial results for the second quarter ended June 30, 2023. The Company also announced a strategic reprioritization to focus on its hunTR® TCR discovery platform, wind down its TCR-T Phase 1/2 Library trial and explore broad strategic alternatives...

Continue reading

Cleantech Building Materials: Notice of General Meeting

Written by Customer Service on . Posted in Public Companies.

14 August 2023 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER:  CBMISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Notice of General Meeting Cleantech Building Materials plc (“CBM” or the “Company”) announces that a General Meeting of the Company will be held on 7 September 2023 at 4.00 p.m. at the offices of Wallace LLP, 27 Mortimer Street, London, W1T 3JF. The General Meeting is being convened as the CBM board has been reviewing the Company’s operating costs and has concluded that the cost of maintaining the listing of the Company’s Ordinary Shares on the Nasdaq First North Growth Market is no longer justified, given the limited liquidity available to shareholders. The Directors therefore believe it is in the best interests of Shareholders that the Company’s Shares be...

Continue reading

How Will the Structural Adhesives Market Transform Itself into a USD 28.99 Billion Powerhouse by 2032?

Written by Customer Service on . Posted in Mergers And Acquisitions.

Increasing use of structural adhesives in various applications is a key factor driving Structural Adhesives market revenue growth. Vancouver, Aug. 14, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Structural Adhesives Market. As organizations strive to improve their manufacturing processes and enhance product performance, the latest analysis from Emergen Research offers invaluable insights that are set to revolutionize strategies in the structural adhesives market across various industries. Structural adhesives play a crucial role in bonding and joining different materials, providing strength, durability,...

Continue reading

Toll Brothers features Amazon’s Just Walk Out Technology at its Regency at Folsom Ranch community near Sacramento

Written by Customer Service on . Posted in Public Companies.

Toll Brothers features Amazon’s Just Walk Out technology Toll Brothers features Amazon’s Just Walk Out technology in its convenience store at the amenity center of Regency at Folsom Ranch, a luxury 55+ active adult community in Folsom, Calif. Toll Brothers Regency at Folsom Ranch “The new checkout-free store powered by Amazon at Regency at Folsom Ranch is just one more way we have embraced technology to give our residents more time and freedom to enjoy life at our new resort-style community,” said Scott Esping, Division President of Toll Brothers in Sacramento. FOLSOM, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the installation of Amazon’s innovative Just Walk Out technology at the convenience store within its Regency at Folsom...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.